The abstract is read at the publisher; the summary is JClub's.
Regular colonoscopic surveillance of 3028 Lynch syndrome MMR carriers at a mean interval of ≤3 years is linked to lower CRC-specific and all-cause mortality, without a change in total CRC incidence.
- Why it matters: National guidance recommends enhanced surveillance for MMR carriers, but real-world adherence and its effect on CRC outcomes in England remain uncertain, especially given possible selection bias.
- What they did: Using a registry of 4732 English NHS patients with Lynch syndrome linked to digital records (2010–2022), the study quantified colonoscopy frequency, modeled adherence with logistic regression, and estimated CRC incidence and mortality with age-specific rates plus Kaplan-Meier and Cox analyses.
- The result: Surveillance at ≤3 years decreased mortality, while surveillance at a mean interval of ≤2 years (n=1569) was associated with higher total CRC incidence and more early-stage cancers, with no corresponding late-stage reduction.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.